Pliant Therapeutics
PLRX
PLRX
134 hedge funds and large institutions have $1.14B invested in Pliant Therapeutics in 2023 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-2
Holders Change %
-1.47%
% of All Funds
1.96%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.1%
New
19
Increased
53
Reduced
34
Closed
20
Calls
$2.06M
Puts
$5.88M
Net Calls
-$3.81M
Net Calls Change
-$4.73M
Top Buyers
1 |
BOCH
Blue Owl Capital Holdings
New York
|
$54.4M |
2 |
Morgan Stanley
New York
|
$14.7M |
3 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
$65M |
4 |
BlackRock
New York
|
$87M |
5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
$68.6M |